Literature DB >> 16340663

Hormonal and cytokine effects of uric acid.

Laura G Sánchez-Lozada1, Takahiko Nakagawa, Duk-Hee Kang, Dan I Feig, Martha Franco, Richard J Johnson, Jaime Herrera-Acosta.   

Abstract

PURPOSE OF REVIEW: Current evidence supports the role of soluble uric acid as a true mediator of injury, exerting its effects through the induction of growth factors, cytokines, hormones and autacoids. In the present review, we summarize recent studies on the mechanisms involved in the uric acid deleterious effects. RECENT
FINDINGS: Although uric acid is considered an antioxidant in plasma, recent clinical and epidemiological studies have found that hyperuricemia is associated with mortality and development of hypertension, cardiovascular and chronic renal diseases. Experimental studies suggest that uric acid induce its detrimental effects at the cellular level entering to vascular smooth muscle cells (VSMC) via an organic anion transport system, and followed by the activation of specific MAP kinases, nuclear transcription factors, with stimulation of COX-2, PDGF A and C chain, PDGF alpha receptor, and various inflammatory mediators, including C-reactive protein and monocyte chemoattractant protein-1. Physiologically, these effects translate into a rise of arterial pressure, VSMC hypertrophy, tubulointerstitial infiltration and glomerular hypertension in the setting of renal vasoconstriction. Uric acid also promotes endothelial dysfunction through inactivation of NO and arresting the proliferation of endothelial cells. Thus, arteriosclerosis induced by hyperuricemia may be a novel mechanism for the development of essential hypertension.
SUMMARY: Soluble uric acid has important biologic roles. While it acts as an antioxidant, there is also evidence that uric acid has pro-inflammatory and proliferative effects on VSMC, and causes dysfunction of endothelial cells. These cellular mechanisms may translate into why uric acid is associated with renal and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16340663     DOI: 10.1097/01.mnh.0000199010.33929.7f

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  15 in total

1.  Concurrent acute spontaneous tumor lysis syndrome complicated with multiple organ failure in a patient with pre-existing undiagnosed lung cancer.

Authors:  Fateme Shamekhi Amiri
Journal:  CEN Case Rep       Date:  2015-04-03

2.  Associations of serum uric acid levels with arterial wave reflections and central systolic blood pressure.

Authors:  Pai-Feng Hsu; Shao-Yuan Chuang; Hao-Min Cheng; Shih-Hsien Sung; Chih-Tai Ting; Edward G Lakatta; Frank C P Yin; Pesus Chou; Chen-Huan Chen
Journal:  Int J Cardiol       Date:  2013-02-27       Impact factor: 4.164

3.  Extracellular guanosine regulates extracellular adenosine levels.

Authors:  Edwin K Jackson; Dongmei Cheng; Travis C Jackson; Jonathan D Verrier; Delbert G Gillespie
Journal:  Am J Physiol Cell Physiol       Date:  2012-12-12       Impact factor: 4.249

Review 4.  Uric acid in metabolic syndrome: From an innocent bystander to a central player.

Authors:  Mehmet Kanbay; Thomas Jensen; Yalcin Solak; Myphuong Le; Carlos Roncal-Jimenez; Chris Rivard; Miguel A Lanaspa; Takahiko Nakagawa; Richard J Johnson
Journal:  Eur J Intern Med       Date:  2015-12-15       Impact factor: 4.487

Review 5.  Sirtuin deficiency and the adverse effects of fructose and uric acid synthesis.

Authors:  Bernardo Rodriguez-Iturbe; Richard J Johnson; Miguel A Lanaspa; Takahiko Nakagawa; Fernando E Garcia-Arroyo; Laura G Sánchez-Lozada
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-03-10       Impact factor: 3.619

6.  Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome.

Authors:  Shuzo Takayama; Ryuichi Kawamoto; Tomo Kusunoki; Masanori Abe; Morikazu Onji
Journal:  Cardiovasc Diabetol       Date:  2012-01-10       Impact factor: 9.951

7.  Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome.

Authors:  Márcio Soares; Guilherme A Feres; Jorge I F Salluh
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

8.  Plasmodium-induced inflammation by uric acid.

Authors:  Jamie M Orengo; James E Evans; Esther Bettiol; Aleksandra Leliwa-Sytek; Karen Day; Ana Rodriguez
Journal:  PLoS Pathog       Date:  2008-03-07       Impact factor: 6.823

9.  Sweetened beverage consumption and the risk of hyperuricemia in Mexican adults: a cross-sectional study.

Authors:  Joacim Meneses-Leon; Edgar Denova-Gutiérrez; Susana Castañón-Robles; Victor Granados-García; Juan O Talavera; Berenice Rivera-Paredez; Gerardo G Huitrón-Bravo; Margarita Cervantes-Rodríguez; Manuel Quiterio-Trenado; Samantha E Rudolph; Jorge Salmerón
Journal:  BMC Public Health       Date:  2014-05-12       Impact factor: 3.295

10.  The urinary cytokine/chemokine signature of renal hyperfiltration in adolescents with type 1 diabetes.

Authors:  Ron L H Har; Heather N Reich; James W Scholey; Denis Daneman; David B Dunger; Rahim Moineddin; R Neil Dalton; Laura Motran; Yesmino Elia; Livia Deda; Masha Ostrovsky; Etienne B Sochett; Farid H Mahmud; David Z I Cherney
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.